HIV I INFECTION
Clinical trials for HIV I INFECTION explained in plain language.
Never miss a new study
Get alerted when new HIV I INFECTION trials appear
Sign up with your email to follow new studies for HIV I INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
HIV vaccine candidate VIR-1388 passes early safety check in 93 volunteers
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new HIV vaccine called VIR-1388 in 93 healthy adults who did not have HIV. The goal was to see if the vaccine is safe and whether it triggers an immune response. Participants received either the vaccine or a placebo, and researchers monitored side …
Matched conditions: HIV I INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:09 UTC
-
Long-acting HIV shot studied in patients with severe kidney problems
Disease control CompletedThis study looks at whether CABENUVA, a long-acting injectable HIV medication, is safe and effective for people with HIV who also have severe kidney impairment, including those on dialysis. Participants receive the drug as monthly or every-2-month injections. The goal is to see h…
Matched conditions: HIV I INFECTION
Phase: PHASE3 • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
HIV drug switch may protect hearts: small study tests doravirine
Disease control CompletedThis completed early-phase trial tested whether switching HIV medications to doravirine (with emtricitabine and tenofovir alafenamide) could improve cholesterol and reduce early signs of artery hardening compared to staying on integrase inhibitors. Twenty-six adults with well-con…
Matched conditions: HIV I INFECTION
Phase: EARLY_PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could giving TB meds at home boost prevention?
Prevention CompletedThis study tested whether giving a full 3-month supply of TB preventive medicine directly in the community helps more people finish their treatment compared to standard clinic visits. Researchers enrolled 301 adults in South Africa who were at risk for TB, including those with HI…
Matched conditions: HIV I INFECTION
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC